… antivirals of proven efficacy for COVID-19, and several drugs … lopinavir/ritonavir association
(LPV/r) use in COVID-19, and … use of LPV/r in COVID-19 were further directly searched on the …

… found that lopinavir–ritonavir treatment did not significantly accelerate clinical improvement,
reduce mortality, or diminish throat viral RNA detectability in patients with serious Covid-19. …

… compared lopinavir–ritonavir with usual care in patients with COVID-19. This trial assigned
99 patients who had been admitted to hospital with COVID-19 to a lopinavir–ritonavir group (…

… A systematic review of lopinavir-ritonavir therapy in patients of … for the use of lopinavir-ritonavir
in the treatment of COVID-19 is now … in COVID-19 patients treated with lopinavir-ritonavir …

… are no approved treatments for Covid-19,4 and … lopinavir–ritonavir. We therefore advocate
that therapeutic guidelines retain lopinavir–ritonavir as a treatment option against Covid-19, …

… studies demonstrated that lopinavir/ritonavir was not effective in treating COVID-19 patients
(18-… of lopinavir/ritonavir compared to other treatment options for treating COVID-19 patients. …

… COVID-19. The study aimed to investigate whether lopinavir/ritonavir (LPV/r) in combination …
other pneumonia-associated adjuvant drugs has a better therapeutic effect on COVID-19. …

… 2020 using the following search string: ‘(lopinavir/ritonavir) AND (randomized OR trial OR …
) AND(COVID-19)’. For medRXiv database, we used ‘lopinavir/ritonavir COVID-19’ as a search …

… (Background) Lopinavir-ritonavir (LPV/RTV) is a human … of COVID-19 disease. (Aim) This
systematic review aimed to assess the efficacy and safety of LPV/RTV in COVID-19 patients in …

… the use of lopinavir/ritonavir in the treatment of COVID-19. As … in further research regarding
lopinavir/ritonavir in COVID-19, in … stage of COVID-19 when lopinavir/ritonavir is administered, …